Bioneer Corporation (KOSDAQ: A064550)
Health Care · Biotechnology · KR
₩9,030.00
+25.07% today · -35.9% 1Y
Bioneer Corporation (KOSDAQ: A064550) operates in the Biotechnology industry within the Health Care sector. The company is valued at $168.17M.
Over the last twelve months the share price has lost 35.9%, trading between 5.47K and 15.64K.
Tweenvest scores Bioneer Corporation across four factors: quality 58/100, value 65/100. Its strongest factor is value.
A064550 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $168.17M
- Revenue (TTM)
- $222.05M
- P/E
- —
- EPS
- -225.12
- Dividend yield
- —
- Beta (5Y)
- 0.32
- 52-week high
- ₩15,640.00
- 52-week low
- ₩5,470.00
- Avg volume (3M)
- —
- Shares outstanding
- 25.81M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.93 | +0.53% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $445.08 | +0.28% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $147.46 | +0.49% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $553.68 | +1.11% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $836.15 | +0.92% |
| argenx SEENXTBR: ARGX | $63.06B | €877.40 | +1.53% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $156.39 | +12.60% |
Figures last refreshed Aug 18, 2026.